News

Productivity savings of €132 million in Q2 brought the YTD total to €258 million, on track to meet the 2026‑2028 program target of €1.5 billion. New product launches included SmartIQ for the Azurion image‑guided therapy platform and the AI‑powered Titanion MR. Strategic deals include a large partnership with a U.S. nonprofit health‑care system and...

Full article

Philips maintained its FY2026 outlook: comparable sales growth 3 %‑4.5 %; adjusted EBITA margin 13.5 %‑14.0 % (including a tariff‑refund benefit of ~1 %) and 12.5 %‑13.0 % excluding the benefit. Net debt stood at €5.7 billion with a leverage ratio of 1.8×. The company completed its 2025 dividend payout in Q2 2026 at a 43.8 % payout ratio and reiter...

Full article

Group sales growth was modest at 1 %, but comparable sales increased 4 %. Order intake fell 1 % in the quarter yet rose 5 % on a rolling 12‑month basis, reflecting sustained commercial momentum. Diagnosis and Treatment sales grew 2.4 %, image‑guided therapy saw high single‑digit growth, Connected Care sales increased 2.2 % with monitoring at mid‑si...

Full article

Philips reported Q2 2026 revenue of €4.4 billion, a 0.9 % year‑over‑year increase and 4 % comparable sales growth, driven by all segments. Net income rose to €386 million from €240 million last year and earnings per share climbed to €0.40 from €0.25. Adjusted EBITA reached €717 million, 16.4 % of sales, up from 12.4 % previously; the uplift include...

Full article

Dividend policy was updated: a dividend of £0.108 per share is approved for the interim period, payable 14 September to shareholders on record 7 August, up from £0.095 per share the previous year. Despite the lower H1 profit, Inchcape expects adjusted EPS growth of more than 10 % for 2026, aligning with its medium‑term guidance. The company’s strat...

Full article

The Accelerate Plus strategy is advancing, focusing on value‑accretive M&A and disciplined capital allocation. The group CEO, Duncan Tate, highlighted that the issues in Australia should improve in the second half, citing better supply from main OEMs and a shift in consumer behaviour toward EVs. Europe and Africa saw a 13 % growth, supported by new...

Full article

Geographically, the United States saw accelerating growth, whereas Asia (excluding Japan) and Europe displayed resilience. The group’s innovation pipeline and diversified luxury brands, including Louis Vuitton and Tiffany & Co., contributed to the positive results. Christian Dior remains confident in sustaining its global leadership amid an uncerta...

Full article

Segment performance underscored the group’s resilience. Fashion & Leather Goods, the largest division, generated €18.1 bn in revenue and €6.2 bn of recurring profit, rebounding to organic growth in Q2 after a full‑year decline. Watches & Jewelry posted 11 % organic revenue growth in Q2, with the Watches segment recording significant gains. Wines &...

Full article

Net financial debt fell 19 % to €8.1 bn, while equity increased 4 % to €67.2 bn. Cash flow remained strong, with €4.1 bn of free cash flow generated. The board announced an interim dividend of €6.05 per share, payable on 3 Dec 2026. EPS rose to €13.25 from €13.13.

Full article

Christian Dior reported first‑half 2026 results that highlighted a modest revenue decline of 3 % to €38.6 bn (€38.64 bn) on a reported basis, largely attributable to a 5 % currency headwind. Despite this, organic revenue grew 3 % year‑on‑year, accelerating to 4 % when excluding the Middle East conflict. Operating margin stood at 22.5 %, and profit...

Full article